NCT01104948View on ClinicalTrials.gov

A Study to Characterize the Pharmacokinetics of DA-8031 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Premature Ejaculatory Dysfunction
Interventions
DRUG

DA-8031

DRUG

Placebo

Trial Locations (1)

110-744

Clinical Research Institute, Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Dong-A Pharmaceutical Co., Ltd.

INDUSTRY